In today's health matters, we may be getting closer to having the first-ever vaccine for malaria.
Final-stage trial data shows an experimental shot from GlaxoSmithKline halved the risk of African children getting Malaria. The vaccine gave protection against the mosquito-borne illness in five-to-17 month old in Africa.
While hailing the achievement, global health experts stressed it was no quick fix for eradicating the disease.
Experts say the new shot is less effective against Malaria than other vaccines are against common infections such as polio and measles.
The World Health Organization says Malaria is endemic in around 100 countries and it killed nearly 800,000 people in 2009.